Menu Search
Equities

Kromek Group PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4KM:FRA

Kromek Group PLC

Actions
  • Price (EUR)0.113
  • Today's Change0.00 / 0.00%
  • Shares traded60.00k
  • 1 Year change+44.87%
  • Beta1.7268
Data delayed at least 15 minutes, as of Feb 11 2026 07:02 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kromek Group plc is a developer of radiation detection and bio-detection technology solutions for advanced imaging and chemical, biological, radiological, and nuclear (CBRN) detection segments. Its advanced imaging segment comprises the medical, security, and industrial markets. The Company provides its original equipment manufacturer customers with detector components based on its core cadmium zinc telluride (CZT) platform, to enable the detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings. In CBRN detection, it provides nuclear radiation detection solutions to the global homeland defense and security market. Its compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of dirty bombs. The Company is also developing bio-security solutions in the CBRN detection segment.

  • Revenue in GBP (TTM)37.84m
  • Net income in GBP12.50m
  • Incorporated2013
  • Employees162.00
  • Location
    Kromek Group PLCNETPark, Thomas Wright WaySEDGEFIELD TS21 3FDUnited KingdomGBR
  • Phone+44 174 062 6060
  • Fax+44 174 062 6061
  • Websitehttps://www.kromek.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.